Literature DB >> 20584630

Anti-allergic potential of oligomannose-coated liposome-entrapped Cry j 1 as immunotherapy for Japanese cedar pollinosis in mice.

Mariko Ishii1, Aki Koyama, Hiroshi Iseki, Hideki Narumi, Naoaki Yokoyama, Naoya Kojima.   

Abstract

Administration of oligomannose-coated liposomes (OMLs) in mice can induce Th1 immune responses against antigens entrapped in the OMLs. In the present study, we investigated the anti-allergic effect of treatment with oligomannose-coated liposomes (OMLs) with entrapped Cry j 1, a major allergen of Japanese cedar pollen (Cry j 1/OMLs), in Balb/c mice sensitized with Cry j 1. Pretreatment of unsensitized mice with Cry j 1/OMLs repressed the elevation of total and allergen-specific IgE levels in sera elicited in response to subsequent sensitization with Cry j 1. Cry j 1-specific IgG1 in sera also decreased in Cry j 1/OML-treated mice, while the levels of Cry j 1-specific IgG2a in these mice significantly increased after sensitization with Cry j 1. In addition, Cry j 1/OML-treated mice showed high IFN-gamma production from spleen cells and low IL-4/IFN-gamma and IL-5/IFN-gamma ratios in response to in vitro stimulation with Cry j 1. These results indicate that allergen-specific Th1 immune responses predominate over Th2 responses and control IgE elevation in Cry j 1/OML-treated mice. The anti-allergic effect of Cry j 1/OML determined by suppression of serum IgE levels was also observed in Cry j 1-presensitized mice after challenge with antigen. Thus, Cry j 1/OMLs may be useful for immunotherapeutic control of allergic reactions to Japanese cedar pollinosis. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20584630     DOI: 10.1016/j.intimp.2010.06.003

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  10 in total

1.  Preferences for uptake of carbohydrate-coated liposomes by C-type lectin receptors as antigen-uptake receptors.

Authors:  Yoko Kawauchi; Yasuhiro Kuroda; Naoya Kojima
Journal:  Glycoconj J       Date:  2012-06-26       Impact factor: 2.916

Review 2.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

Review 3.  Next generation immunotherapy for tree pollen allergies.

Authors:  Yan Su; Eliezer Romeu-Bonilla; Teri Heiland
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

4.  In vitro activation and maturation of human mononuclear phagocytes by stimulation with liposomes coated with a neoglycolipid containing α1-3, α1-6-mannotriose.

Authors:  Yuko Matsuoka; Yoko Kawauchi; Kiyotaka Kawauchi; Akari Takiyama; Shohei Kojima; Yasuhiro Kuroda; Naoya Kojima
Journal:  Glycoconj J       Date:  2019-04-23       Impact factor: 2.916

5.  Liposomes and nanotechnology in drug development: focus on oncotargets.

Authors:  Tomohiro Kozako; Naomichi Arima; Makoto Yoshimitsu; Shin-Ichro Honda; Shinji Soeda
Journal:  Int J Nanomedicine       Date:  2012-09-14

6.  Oral immunotherapy for pollen allergy using T-cell epitope-containing egg white derived from genetically manipulated chickens.

Authors:  Yoshinori Kawabe; Yuuki Hayashida; Kensaku Numata; Shota Harada; Yoshifumi Hayashida; Akira Ito; Masamichi Kamihira
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

Review 7.  Nanoparticle-allergen complexes for allergen immunotherapy.

Authors:  Gabriella Di Felice; Paolo Colombo
Journal:  Int J Nanomedicine       Date:  2017-06-19

Review 8.  Oligomannose-coated liposome as a novel adjuvant for the induction of cellular immune responses to control disease status.

Authors:  Naoya Kojima; Mariko Ishii; Yoko Kawauchi; Hideaki Takagi
Journal:  Biomed Res Int       Date:  2013-10-10       Impact factor: 3.411

9.  Cabazitaxel liposomes with aptamer modification enhance tumor‑targeting efficacy in nude mice.

Authors:  Yuzhu Cheng; Zhanlun Ou; Qingguo Li; Juan Yang; Min Hu; Yubin Zhou; Xiaodong Zhuang; Zhenyu Jason Zhang; Shixia Guan
Journal:  Mol Med Rep       Date:  2018-11-23       Impact factor: 2.952

Review 10.  Formulations for Allergen Immunotherapy in Human and Veterinary Patients: New Candidates on the Horizon.

Authors:  Isabella Pali-Schöll; Douglas J DeBoer; Claudia Alessandri; Ahmed Adel Seida; Ralf S Mueller; Erika Jensen-Jarolim
Journal:  Front Immunol       Date:  2020-08-04       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.